Novel siRNA Therapeutic Cuts Liver Fat in MASLD, Early Trial Shows

Summary
(MedPage Today) -- One dose of a novel small interfering RNA (siRNA) therapy -- CIDEBsiRNA (also known as ALN-CIDEB) -- led to normal liver fat content and lower alanine aminotransferase (ALT) levels in most patients with metabolic dysfunction...
Description from Medpagetoday.
Who is covering this
-
Novel siRNA Therapeutic Cuts Liver Fat in MASLD, Early Trial Shows
(MedPage Today) -- One dose of a novel small interfering RNA (siRNA) therapy -- CIDEBsiRNA (also known as ALN-CIDEB) -- led to normal liver fat content and lower alanine aminotransferase (ALT) levels in most patients with metabolic dysfunction...
Comments
Comments need JavaScript.